Brecanavir (GW640385 or VX-385)

What is brecanavir?

• Brecanavir is an experimental protease inhibitor being developed by GlaxoSmithKline and Vertex Pharmaceuticals. It has not yet been evaluated by the U.S. Food and Drug Administration (FDA) for use by people living with HIV.

Development of V82L/T Mutation Following Tipranavir Therapy Has Limited Effect on Susceptibility to Darunavir and Brecanavir
3/16/07

GlaxoSmithKline Halts Clinical Development of Experimental PI Brecanavir
1/05/07

HIV and AIDS: Top News Articles   HIV and AIDS: FDA-approved Treatments  HIV and AIDS: Experimental Treatments HIV and AIDS: Library of CME Programs